New AIM admission: Belluscura

Medical devices developer Belluscura has gained FDA clearance for its portable oxygen concentrator (POC) and it is on course to start selling the POC device in the next few months. The oxygen market is worth billions of dollars and portable oxygen concentrators are the fastest growing part of the market. Covid-19 has accelerated demand for oxygen, although not as much at the portable end of the market.

There are other products that use the same basic technology that are being developed and c...

You are unauthorized to view this page.

Latest News

More Articles Like This

Tagdiv Cloud library - template content.